Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014;90(7):235-50.
doi: 10.2183/pjab.90.235.

Control of synaptic function by endocannabinoid-mediated retrograde signaling

Affiliations
Review

Control of synaptic function by endocannabinoid-mediated retrograde signaling

Masanobu Kano. Proc Jpn Acad Ser B Phys Biol Sci. 2014.

Abstract

Since the first reports in 2001, great advances have been made towards the understanding of endocannabinoid-mediated synaptic modulation. Electrophysiological studies have revealed that one of the two major endocannabinoids, 2-arachidonoylglycerol (2-AG), is produced from membrane lipids upon postsynaptic Ca(2+) elevation and/or activation of Gq/11-coupled receptors, and released from postsynaptic neurons. The released 2-AG then acts retrogradely onto presynaptic cannabinoid CB1 receptors and induces suppression of neurotransmitter release either transiently or persistently. These forms of 2-AG-mediated retrograde synaptic modulation are functional throughout the brain. The other major endocannabinoid, anandamide, mediates a certain form of endocannabinoid-mediated long-term depression (LTD). Anandamide also functions as an agonist for transient receptor potential vanilloid receptor type 1 (TRPV1) and mediates endocannabinoid-independent and TRPV1-dependent forms of LTD. It has also been demonstrated that the endocannabinoid system itself is plastic, which can be either up- or down-regulated by experimental or environmental conditions. In this review, I will make an overview of the mechanisms underlying endocannabinoid-mediated synaptic modulation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Key features of 2-AG signaling. PLC hydrolyzes arachidonic acid-containing membrane phospholipid such as phosphatidylinositol (PI) and generates diacylglycerol (DG), which is then converted to 2-AG by DGL. The 2-AG released from the postsynaptic neuron enters into the presynaptic membrane, activates CB1R and is degraded by presynaptic MGL. In the postsynaptic neuron, 2-AG is degraded by ABHD6 or oxigenated by COX-2. Activation of presynaptic CB1R causes suppression of neurotransmitter release through inhibition of Ca2+ channels or some other mechanisms. (Reproduced from Ohno-Shosaku et al., 201215)).
Figure 2.
Figure 2.
Representative cases for Ca2+-driven endocannabinoid release (CaER) and Ca2+-assisted Receptor-driven endocannabinoid release (RER). A. Representative data showing DSI, a form of CaER, in a neuron pair from a hippocampal culture. The presynaptic neuron was stimulated and inhibitory postsynaptic currents (IPSCs) were recorded from the postsynaptic neuron. Amplitudes of IPSCs were plotted as a function of time (upper panel) and IPSCs recorded at the indicated time points were shown in the lower panels. Depolarizing pulses (to 0 mV for 5 sec) to the postsynaptic neuron (downward arrow) induced a transient suppression of IPSCs (DSI). After treatment of the CB1 antagonist AM281, DSI was abolished. (Reproduced from Hashimotodani et al., 200728)). B. Representative data showing Ca2+-assisted RER in a neuron pair from a hippocampal culture. Time course of IPSC amplitude (left panel) and IPSC recorded at the indicated time points (right panels) were shown. Application of a low concentration of the muscarinic agonist oxotremorine-M (oxo-M, 0.3 µM) or a weak depolarizing pulse (downward arrow) caused no detectable suppression of IPSCs when applied alone. However, combined application of these two caused a robust suppression of IPSCs. (Reproduced from Hashimotodani et al., 200560)).
Figure 3.
Figure 3.
Molecular mechanisms of eCB-STD. When a large Ca2+ elevation is caused by activation of voltage-gated Ca2+ channels or NMDARs, 2-AG is generated in a DGLα-dependent manner (a, CaER). A key enzyme of this pathway, which is expected to be activated by Ca2+ elevation and produce diacylglycerol, is not identified. When PLCβ is stimulated by activation of Gq/11-coupled receptors, diacylglycerol is generated and converted to 2-AG by DGLα (b, RER). When subthreshold activation of Gq/11-coupled receptors is combined with a small Ca2+ elevation, 2-AG is produced through PLCβ-dependent pathway because the receptor-driven PLCβ stimulation is Ca2+-dependent (c, Ca2+-assisted RER). 2-AG is released from postsynaptic neurons, activates presynaptic CB1R, and induces transient suppression of transmitter release. (Reproduced with modification from Ohno-Shosaku et al., 201215)).
Figure 4.
Figure 4.
Molecular mechanisms of eCB-LTD. Excitatory synaptic inputs activate group I mGluR, which facilitates 2-AG synthesis through PLCβ-DGLα pathway. This mGluR-driven 2-AG synthesis is enhanced by concomitant Ca2+ elevation, which is not necessary for eCB-LTD induction at some synapses. Activation of presynaptic CB1R by 2-AG inhibits adenylyl cyclase (AC), decreases cAMP levels and reduces PKA activity. Presynaptic activity causes Ca2+ elevation, which activates a phosphatase, calcineurin (CaN). In concert with reduced PKA activity, calcineurin facilitates dephosphorylation of target proteins (X), and induces persistent suppression of transmitter release through RIM1α-dependent and/or -independent processes. (Reproduced from Ohno-Shosaku et al., 201215)).

Similar articles

Cited by

References

    1. Iversen, L. (2000) The Science of Marijuana. Oxford University Press, Inc., New York.
    1. Katzung, B.G., Masters, S.B. and Trevor, A.J. (2009) Basic and Clinical Pharmacology. MaGraw-Hill Companies, Inc., New York.
    1. Gaoni Y., Mechoulam R. (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646–1647.
    1. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561–564. - PubMed
    1. Munro S., Thomas K.L., Abu-Shaar M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61–65. - PubMed

Publication types

MeSH terms

Substances